Mackenzie Financial’s Xylem XYL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.69M | Sell |
39,702
-10,576
| -21% | -$1.22M | ﹤0.01% | 845 |
|
|
2026
Q1 | $6.01M | Sell |
50,278
-43,657
| -46% | -$5.72M | 0.01% | 622 |
|
|
2025
Q4 | $12.9M | Buy |
93,935
+51,575
| +122% | +$7.42M | 0.02% | 457 |
|
|
2025
Q3 | $6.25M | Buy |
42,360
+759
| +2% | +$105K | 0.01% | 589 |
|
|
2025
Q2 | $5.38M | Buy |
41,601
+128
| +0.3% | +$15.5K | 0.01% | 593 |
|
|
2025
Q1 | $4.95M | Buy |
41,473
+2,125
| +5% | +$263K | 0.01% | 584 |
|
|
2024
Q4 | $4.57M | Buy |
39,348
+1,883
| +5% | +$238K | 0.01% | 589 |
|
|
2024
Q3 | $5.06M | Buy |
37,465
+2,292
| +7% | +$307K | 0.01% | 540 |
|
|
2024
Q2 | $4.77M | Sell |
35,173
-6,045
| -15% | -$822K | 0.01% | 561 |
|
|
2024
Q1 | $5.33M | Sell |
41,218
-3,714
| -8% | -$449K | 0.01% | 545 |
|
|
2023
Q4 | $5.14M | Sell |
44,932
-3,708
| -8% | -$370K | 0.01% | 548 |
|
|
2023
Q3 | $4.38M | Buy |
48,640
+6,208
| +15% | +$640K | 0.01% | 566 |
|
|
2023
Q2 | $4.75M | Buy |
42,432
+3,226
| +8% | +$341K | 0.01% | 560 |
|
|
2023
Q1 | $4.1M | Buy |
39,206
+23,734
| +153% | +$2.48M | 0.01% | 589 |
|
|
2022
Q4 | $1.71M | Buy |
15,472
+2,529
| +20% | +$265K | ﹤0.01% | 708 |
|
|
2022
Q3 | $1.13M | Buy |
12,943
+274
| +2% | +$24.9K | ﹤0.01% | 797 |
|
|
2022
Q2 | $990K | Buy |
12,669
+800
| +7% | +$66.1K | ﹤0.01% | 841 |
|
|
2022
Q1 | $1.01M | Buy |
11,869
+1,175
| +11% | +$113K | ﹤0.01% | 891 |
|
|
2021
Q4 | $1.28M | Sell |
10,694
-252
| -2% | -$31.3K | ﹤0.01% | 853 |
|
|
2021
Q3 | $1.35M | Buy |
10,946
+3,265
| +43% | +$420K | ﹤0.01% | 839 |
|
|
2021
Q2 | $921K | Buy |
7,681
+407
| +6% | +$46.5K | ﹤0.01% | 895 |
|
|
2021
Q1 | $765K | Buy |
7,274
+2,941
| +68% | +$298K | ﹤0.01% | 857 |
|
|
2020
Q4 | $441K | Buy |
4,333
+268
| +7% | +$25.2K | ﹤0.01% | 866 |
|
|
2020
Q3 | $342K | Buy |
4,065
+53
| +1% | +$4.13K | ﹤0.01% | 853 |
|
|
2020
Q2 | $261K | Buy |
4,012
+47
| +1% | +$3.1K | ﹤0.01% | 897 |
|
|
2020
Q1 | $258K | Buy |
3,965
+515
| +15% | +$40.6K | ﹤0.01% | 937 |
|
|
2019
Q4 | $272K | Sell |
3,450
-20,294
| -85% | -$1.58M | ﹤0.01% | 970 |
|
|
2019
Q3 | $1.89M | Sell |
23,744
-50
| -0.2% | -$3.93K | 0.01% | 618 |
|
|
2019
Q2 | $1.99M | Sell |
23,794
-43,427
| -65% | -$3.46M | 0.01% | 634 |
|
|
2019
Q1 | $5.31M | Buy |
67,221
+16,813
| +33% | +$1.23M | 0.01% | 505 |
|
|
2018
Q4 | $3.36M | Sell |
50,408
-6,634
| -12% | -$459K | 0.01% | 602 |
|
|
2018
Q3 | $4.56M | Buy |
57,042
+333
| +0.6% | +$24.9K | 0.01% | 511 |
|
|
2018
Q2 | $3.82M | Buy |
56,709
+20,548
| +57% | +$1.49M | 0.01% | 501 |
|
|
2018
Q1 | $2.78M | Buy |
36,161
+8,512
| +31% | +$629K | 0.01% | 518 |
|
|
2017
Q4 | $1.89M | Buy |
27,649
+18,084
| +189% | +$1.2M | ﹤0.01% | 543 |
|
|
2017
Q3 | $599K | Hold |
9,565
| – | – | ﹤0.01% | 501 |
|
|
2017
Q2 | $530K | Buy |
9,565
+1,565
| +20% | +$81.5K | ﹤0.01% | 512 |
|
|
2017
Q1 | $402K | Buy |
+8,000
| New | +$390K | ﹤0.01% | 543 |
|
Other funds holding XYL
Mackenzie Financial's XYL Position: Q2 2026 in Review
Mackenzie Financial reduced its Xylem (XYL) stake by 21% in Q2 2026, selling an estimated $1.22M and leaving 39,702 shares worth $4.69M. The position accounts for ﹤0.01% of the portfolio, ranked #845.
Mackenzie Financial first reported a position in XYL in Q1 2017 and has held it in 38 quarters since. The position peaked at $12.9M in Q4 2025. 1,092 funds tracked by Wall St. Rank hold XYL as of Q2 2026.
- Mackenzie Financial held 39,702 shares of Xylem worth $4.69M as of Q2 2026.
- Mackenzie Financial sold 10,576 Xylem shares in Q2 2026, an estimated $1.22M.
- Xylem made up ﹤0.01% of Mackenzie Financial's portfolio in Q2 2026, its #845 holding.
- Mackenzie Financial first reported a position in Xylem in Q1 2017 and has held it in 38 quarters since.
- Mackenzie Financial's Xylem position peaked at $12.9M in Q4 2025.
- 1,092 funds tracked by Wall St. Rank held Xylem as of Q2 2026.
Based on Mackenzie Financial's 13F filing for Q2 2026, filed 13 Aug 2026.